Cargando…

Different Inflammatory Signatures in Alzheimer’s Disease and Frontotemporal Dementia Cerebrospinal Fluid

BACKGROUND: Neuroinflammatory processes are common in neurodegenerative diseases such as Alzheimer’s disease (AD) and frontotemporal dementia (FTD), but current knowledge is limited as to whether cerebrospinal fluid (CSF) levels of neuroinflammatory proteins are altered in these diseases. OBJECTIVE:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boström, Gustaf, Freyhult, Eva, Virhammar, Johan, Alcolea, Daniel, Tumani, Hayrettin, Otto, Markus, Brundin, Rose-Marie, Kilander, Lena, Löwenmark, Malin, Giedraitis, Vilmantas, Lleó, Alberto, von Arnim, Christine A.F., Kultima, Kim, Ingelsson, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203220/ https://www.ncbi.nlm.nih.gov/pubmed/33814444 http://dx.doi.org/10.3233/JAD-201565

Ejemplares similares

Mutation analysis of disease causing genes in patients with early onset or familial forms of Alzheimer’s disease and frontotemporal dementia
por: Pagnon de la Vega, María, et al.
Publicado: (2022)

Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases
por: Braun, Madelene, et al.
Publicado: (2023)

Improved Differential Diagnosis of Alzheimer’s Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers
por: Khoonsari, Payam Emami, et al.
Publicado: (2019)

Imaging features associated with idiopathic normal pressure hydrocephalus have high specificity even when comparing with vascular dementia and atypical parkinsonism
por: Fällmar, David, et al.
Publicado: (2021)

Mixed Pathologies in a Subject with a Novel PSEN1 G206R Mutation
por: Libard, Sylwia, et al.
Publicado: (2022)

Dual-Task Performance and Neurodegeneration: Correlations Between Timed Up-and-Go Dual-Task Test Outcomes and Alzheimer’s Disease Cerebrospinal Fluid Biomarkers
por: Åhman, Hanna Bozkurt, et al.
Publicado: (2019)

Dual-Task Tests Predict Conversion to Dementia—A Prospective Memory-Clinic-Based Cohort Study
por: B Åhman, Hanna, et al.
Publicado: (2020)

Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease
por: Khoonsari, Payam Emami, et al.
Publicado: (2016)

Dual-task tests discriminate between dementia, mild cognitive impairment, subjective cognitive impairment, and healthy controls – a cross-sectional cohort study
por: Åhman, Hanna B., et al.
Publicado: (2020)

High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer’s disease
por: Degerman Gunnarsson, Malin, et al.
Publicado: (2016)

Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases
por: Jesse, Sarah, et al.
Publicado: (2010)

White matter changes should not exclude patients with idiopathic normal pressure hydrocephalus from shunt surgery
por: Snöbohm, Carl, et al.
Publicado: (2022)

Increased Levels of Antigen-Bound β-Amyloid Autoantibodies in Serum and Cerebrospinal Fluid of Alzheimer’s Disease Patients
por: Maftei, Madalina, et al.
Publicado: (2013)

Metabolomics of Cerebrospinal Fluid from Healthy Subjects Reveal Metabolites Associated with Ageing
por: Carlsson, Henrik, et al.
Publicado: (2021)

Cerebrospinal fluid cytokines after autologous haematopoietic stem cell transplantation and intrathecal rituximab treatment for multiple sclerosis
por: Burman, Joachim, et al.
Publicado: (2023)

Cerebrospinal Fluid Immunoglobulin Kappa Light Chain in Clinically Isolated Syndrome and Multiple Sclerosis
por: Senel, Makbule, et al.
Publicado: (2014)

Cerebrospinal Fluid in Classical Trigeminal Neuralgia: An Exploratory Study on Candidate Biomarkers
por: Svedung Wettervik, Teodor, et al.
Publicado: (2022)

Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory
por: Ljubenkov, Peter A., et al.
Publicado: (2018)

Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?
por: Abdelhak, Ahmed, et al.
Publicado: (2015)

Protein Biomarkers for Insulin Resistance and Type 2 Diabetes Risk in Two Large Community Cohorts
por: Nowak, Christoph, et al.
Publicado: (2016)

APP‐derived peptides reflect neurodegeneration in frontotemporal dementia
por: Illán‐Gala, Ignacio, et al.
Publicado: (2019)

Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s disease
por: Bergström, Sofia, et al.
Publicado: (2021)

Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus
por: Braun, Madelene, et al.
Publicado: (2022)

Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis
por: Robinson, Tilman, et al.
Publicado: (2020)

Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia
por: Sogorb-Esteve, Aitana, et al.
Publicado: (2022)

Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration
por: Cervantes González, Alba, et al.
Publicado: (2022)

Automated Analysis of Cerebrospinal Fluid Cells Using Commercially Available Blood Cell Analysis Devices—A Critical Appraisal
por: Wick, Manfred, et al.
Publicado: (2021)

Decreased CX3CL1 Levels in the Cerebrospinal Fluid of Patients With Alzheimer’s Disease
por: Perea, Juan R., et al.
Publicado: (2018)

Mosaic Loss of Chromosome Y in Blood Is Associated with Alzheimer Disease
por: Dumanski, Jan P., et al.
Publicado: (2016)

Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia
por: Bibl, Mirko, et al.
Publicado: (2012)

Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia
por: Landqvist Waldö, Maria, et al.
Publicado: (2013)

Cerebrospinal Fluid Biomarker Profile in TDP-43-Related Genetic Frontotemporal Dementia
por: Kapaki, Elisabeth, et al.
Publicado: (2022)

Cerebrospinal fluid–related tissue damage in multiple sclerosis patients with iron rim lesions
por: Wittayer, Matthias, et al.
Publicado: (2023)

Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers
por: Remnestål, Julia, et al.
Publicado: (2020)

Decreased IL-8 levels in CSF and serum of AD patients and negative correlation of MMSE and IL-1β
por: Hesse, Raphael, et al.
Publicado: (2016)

Neurochemical Biomarkers in patients with COVID-19
por: Tumani, Hayrettin
Publicado: (2023)

Cognitive function in very old men does not correlate to biomarkers of Alzheimer’s disease
por: Velickaite, V., et al.
Publicado: (2017)

Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics
por: Teunissen, Charlotte E., et al.
Publicado: (2016)

Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest
por: Foiani, Martha S, et al.
Publicado: (2019)

Monoaminergic and Kynurenergic Characterization of Frontotemporal Dementia and Amyotrophic Lateral Sclerosis in Cerebrospinal Fluid and Serum
por: Janssens, Jana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eafj9mch4487kdqa44tjo0eqcn